Redx Pharma
Phase 2Redx is a clinical-stage biotechnology company focused on the development of novel, small molecule, targeted medicines for the treatment of fibrotic disease
Founded
2010
Focus
Small Molecules
About
Redx is a clinical-stage biotechnology company focused on the development of novel, small molecule, targeted medicines for the treatment of fibrotic disease
Funding History
4Total raised: $86M
IPOUndisclosedUndisclosedMar 15, 2021
Series C$28MRedmile GroupMar 15, 2017
Series B$33MNovo HoldingsJun 15, 2015
Series A$25MArix BioscienceJan 15, 2013
Company Info
TypePrivate
Founded2010
LocationAlderley Park, United Kingdom
StagePhase 2
Contact
Sectors
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile